| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +5,450% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +172% |
| 3Y CAGR | -45% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹18,944.00 -44.00 (0.23%) | 24,269.60 | 66.68 | 12.95 | ||
PfizerPFIZER | ₹4,568.60 +129.20 (2.91%) | 20,884.75 | 28.91 | 4.97 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹8,310.50 +68.50 (0.83%) | 20,744.75 | 110.62 | 23.77 | ||
Granules IndiaGRANULES | ₹833.80 +8.10 (0.98%) | 20,645.20 | 34.7 | 4.06 |